NVDA

111.25

+4.49%↑

AVGO.US

192.06

+2.37%↑

ORCL

138.21

+0.7%↑

ASML.US

677.65

+0.86%↑

CRM

268.04

+1.31%↑

NVDA

111.25

+4.49%↑

AVGO.US

192.06

+2.37%↑

ORCL

138.21

+0.7%↑

ASML.US

677.65

+0.86%↑

CRM

268.04

+1.31%↑

NVDA

111.25

+4.49%↑

AVGO.US

192.06

+2.37%↑

ORCL

138.21

+0.7%↑

ASML.US

677.65

+0.86%↑

CRM

268.04

+1.31%↑

NVDA

111.25

+4.49%↑

AVGO.US

192.06

+2.37%↑

ORCL

138.21

+0.7%↑

ASML.US

677.65

+0.86%↑

CRM

268.04

+1.31%↑

NVDA

111.25

+4.49%↑

AVGO.US

192.06

+2.37%↑

ORCL

138.21

+0.7%↑

ASML.US

677.65

+0.86%↑

CRM

268.04

+1.31%↑

Genpact Ltd

Отворен

СекторТехнологични

47.75 -0.38

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

47.21

Максимум

47.9

Ключови измерители

By Trading Economics

Приходи

9.1M

142M

Продажби

38M

1.2B

P/E

Средно за сектора

16.379

86.529

EPS

0.91

Дивидентна доходност

1.43

Марж на печалбата

11.365

Служители

140,000

EBITDA

22M

228M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+17.57% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.43%

2.52%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-340M

8.2B

Предишно отваряне

48.13

Предишно затваряне

47.75

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Genpact Ltd Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

13.03.2025 г., 06:45 ч. UTC

Печалби

Generali Operating Profit Rises on Higher Premiums

22.04.2025 г., 10:57 ч. UTC

Пазарно говорене

Generali Shareholder Norges to Vote in Favor of Board Reappointment -- Market Talk

10.04.2025 г., 08:53 ч. UTC

Пазарно говорене

Proxy Advisor Glass Lewis Backs Generali Board Reappointment -- Market Talk

7.04.2025 г., 11:08 ч. UTC

Пазарно говорене

Renewal of Generali Board Supported by Proxy ISS -- Market Talk

1.04.2025 г., 13:31 ч. UTC

Топ новини
Придобивния, сливания и поглъщания

European Insurers Will Be Slower Than Banks to Consolidate, Generali Executive Says -- Interview

1.04.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Trends in European Insurance Are Fundamentally Positive, Consumer Demand Is Strong, Terzariol Says

1.04.2025 г., 13:31 ч. UTC

Придобивния, сливания и поглъщания

Smaller Insurance Players Might Become M&A Targets if Conditions Become Challenging, Terzariol Says

1.04.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

Fewer European Insurers Will Be Around in 10, 20 Years, Generali's Terzariol Says

1.04.2025 г., 13:30 ч. UTC

Придобивния, сливания и поглъщания

European Insurers to Consolidate at Gradual Pace, Generali's Insurance Chief Says

1.04.2025 г., 08:09 ч. UTC

Пазарно говорене

Generali's Board Tussle Is Main Risk for Shares -- Market Talk

1.04.2025 г., 07:52 ч. UTC

Пазарно говорене
Печалби

European Insurers Liked by North American Investors -- Market Talk

31.03.2025 г., 08:09 ч. UTC

Пазарно говорене

Mediobanca's List for Generali's Board Likely to Be Supported, Equita Says -- Market Talk

13.03.2025 г., 08:00 ч. UTC

Пазарно говорене
Печалби

Generali's Dividend Growth Stands Out -- Market Talk

13.03.2025 г., 07:57 ч. UTC

Пазарно говорене
Печалби

Generali's Results Look Solid -- Market Talk

13.03.2025 г., 06:07 ч. UTC

Печалби

Generali Backs 2025-27 Targets

13.03.2025 г., 06:05 ч. UTC

Печалби

Generali End 2024 AUM EUR863B

13.03.2025 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2024 Dividend EUR1.40

13.03.2025 г., 06:04 ч. UTC

Печалби

Generali Proposes EUR1.43 Dividend Per Share

13.03.2025 г., 06:04 ч. UTC

Печалби

Generali 2024 New Business Margin 4.60%

13.03.2025 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali End 2024 Solvency Ratio 211%

13.03.2025 г., 06:04 ч. UTC

Печалби

Generali End 2024 Solvency Ratio 210%

13.03.2025 г., 06:04 ч. UTC

Печалби

Analysts Saw Generali 2024 Combined Ratio 94.0%

13.03.2025 г., 06:04 ч. UTC

Печалби

Generali 2024 Combined Ratio 94.0%

13.03.2025 г., 06:03 ч. UTC

Печалби

Analysts Saw Generali 2024 Oper Result EUR7.23B

13.03.2025 г., 06:03 ч. UTC

Печалби

Generali 2024 Oper Pft EUR7.295B

13.03.2025 г., 06:03 ч. UTC

Печалби

Analysts Saw Generali 2024 Gross Written Premiums EUR94.21B

13.03.2025 г., 06:03 ч. UTC

Печалби

Generali 2024 Gross Written Premiums EUR95.19B

13.03.2025 г., 06:03 ч. UTC

Печалби

Analysts Saw Generali 2024 Adj. Net Pft EUR3.76B

13.03.2025 г., 06:03 ч. UTC

Печалби

Generali 2024 Adj. Net Pft EUR3.77B

13.03.2025 г., 06:03 ч. UTC

Печалби

Analysts Saw Generali 2024 Net Pft EUR3.825B

Сравнение с други в отрасъла

Ценова промяна

Genpact Ltd Прогноза

Ценова цел

By TipRanks

17.57% нагоре

12-месечна прогноза

Среден 56.22 USD  17.57%

Висок 58 USD

Нисък 55 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Genpact Ltd през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

9 ratings

4

Купи

5

Задържане

0

Продай

Техническа оценка

By Trading Central

4.6 / 4.8Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Weak Bearish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Genpact Ltd

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.